PP 2.9 – 00125 Impact of latency reversal agents on estrogen receptor alpha gene and protein expression by C. Ceriani, K.L. Lemu, A. Abeyta-Lopez, B. Allard, K.S. James, D.M. Margolis, N.M. Archin

Get full text

Induction of HIV from latency by a novel molecule by N.M. Archin, D. Boden, J. Kirchherr, B. Allard, K. Sholtis, J.D. Kuruc, G. Kraus, D.M. Margolis

Get full text

PP 1.4 – 00037 Histone decrotonylation uniquely regulates HIV-1 transcription and can be modulated to control HIV-1 latency by T.L. Simermeyer, D. Li, L.M. Wong, C. Aquino, Y. Tang, E.P. Browne, N.M. Archin, D.M. Margolis, G. Jiang

Get full text

Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5 by A. Bosque, A. Macedo, A. Spivak, C.L. Novis, L.J. Martins, M. Szaniawski, N.M. Archin, P.A. Luciw, D.M. Margolis, V. Planelles

Get full text

The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection by C. Gay, J.D. Kuruc, S.D. Falcinelli, J. Warren, J.L. Kirchherr, K. Sholtis, B. Allard, E. Stuelke, A. Gamble, A. Plachco, I. Tcherapanova, J.J. Eron, N. Goonetilleke, M. DeBenedette, C.A. Nicolette, N.M. Archin, D.M. Margolis

Get full text

OP 1.4 – 00053 Definitive evidence of a persistent HIV reservoir in human brain myeloid cells despite ART by Y. Tang, G. Jiang, M. Porrachia, C. Ignacio, L.M. Wong, D. Zhong, J. Du, B. Cotsakis, S. Maske, E. de la Parra Polina, T.L. Simermeyer, D. Li, B. Woodworth, J. Kirchherr, B. Allard, M. Clohosey, G.D. Whitehill, J.J. Eron, N.M. Archin, S.B. Joseph, K. Bar, A. Chaillon, S. Gianella, D.M. Margolis, G. Jiang

Get full text